Agile Therapeutics (AGRX) Q4 2021 Earnings Call Transcript
Hello, everyone, and welcome to today's conference call to discuss our fourth quarter and full year 2021 financial results and corporate update. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, our outlook for the first quarter of 2022, management's expectations for our future financial and operational performance, our business strategy and our assessment of the combined hormonal contraceptive market, among other statements regarding our plans, prospects and expectations.